The COVID-19 pandemic will have a significant impact on the Indian diagnostic imaging market in the short term. Once the market stabilizes, however, the emerging diagnostic imaging system market in India will see strong growth through 2029, fueled by favorable demographics and underpenetration of the market; increasing procedure volumes and government investment in health care will be important factors supporting market expansion.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for Diagnostic Imaging Systems in India across a 10-year period.
The COVID-19 pandemic will affect the Indian diagnostic imaging system market.
To what extent will the COVID-19 pandemic impact the Indian diagnostic imaging system market?
How will the impact of the COVID-19 pandemic differ between segments?
Market growth in India will be primarily driven by increasing procedure volumes and government investment in diagnostic imaging systems.
Which product segments will exhibit the strongest growth in the Indian market?
How do the types of systems purchased differ between private and public facilities?
At what rate will refurbished MRI and CT system use increase through the forecast period?
Ultrasound systems will exhibit slow adoption in India through 2029.
Which type of ultrasound systems will see the strongest adoption in India?
How do trends in the Indian ultrasound system market compare to global trends?
To what extent will the PNDT Act and governmental restrictions on portable ultrasound use influence growth of the ultrasound market as a whole?
How can competitors best respond to market limiters in order to gain market share within the ultrasound system space?
MNCs have a strong presence in the Indian diagnostic imaging system market.
How are MNCs tailoring their products to best suit the Indian market?
- Diagnostic Imaging Systems - Market Insights - India
Author(s): Hebri Nandita Mallya
Hebri Nandita Mallya is a research associate within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, specializing in Diagnostic Imaging Systems market. Hebri Nandita Mallya holds a Bachelor's degree in Biotechnology, Chemistry and Zoology from Christ University, Bangalore, and a Master's degree in Medical Biochemistry from Manipal Academy of Higher Education.